Table 1 Clinical characteristics of included patients
From: Coagulation biomarkers and coronavirus disease 2019 phenotyping: a prospective cohort study
|  | Survivor (n = 160) | Non-Survivor (n = 53) | p-value* |
|---|---|---|---|
Gender, male, n (%) | 61 (38) | 16 (30) | 0.32 |
Age, mean (SD) | 53 (15) | 62 (13) |  < 0.001 |
Need for mechanical ventilation, n (%) | 46 (29) | 37 (70) |  < 0.001 |
Thorax CT scan extension of lesions > 50%, n (%) | 51 (32) | 28 (53) | 0.023 |
Charlson comorbidity index, mean (SD) | 1.62 (1.5) | 2.34 (1.65) | 0.004 |
BMI, mean (SD) | 26 (10) | 29 (5) | 0.026 |
SOFA at admission, mean (SD) | 2.78 (2.2) | 5.28 (3.6) |  < 0.001 |
SAPS III score, mean (SD) | 39 (25) | 58 (20) |  < 0.001 |
Respiratory SOFA, mean (SD) | 1.98 (1) | 2.43 (1) | 0.009 |